DLH Holdings Corp(DLHC) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 30 at 4:00 PM ET (Korea 10/31 05:00)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -1.49 | Insider Own | 17.53% | Shs Outstand | 14.5M | Perf Week | -3.71% |
| Market Cap | 0.05B | Forward P/E | - | EPS next Y | 9.21% | Insider Trans | 8.75% | Shs Float | 11.9M | Perf Month | -1.36% |
| Enterprise Value | 0.19B | PEG | - | EPS next Q | -0.28 | Inst Own | 83.77% | Short Float | 0.36% | Perf Quarter | -27.69% |
| Income | -0.02B | P/S | 0.21 | EPS this Y | -944.44% | Inst Trans | 0.96% | Short Ratio | 3.04 | Perf Half Y | -36.98% |
| Sales | 0.25B | P/B | 0.56 | EPS next 5Y | - | ROA | -7.78% | Short Interest | 0.04M | Perf YTD | -35.75% |
| Book/sh | 6.44 | P/C | 228.72 | EPS past 3/5Y | -61.44% -29.55% | ROE | -20.84% | 52W High | -55.19% ($8.10) | Perf Year | -40.49% |
| Cash/sh | 0.02 | P/FCF | 3.8 | Sales past 3/5Y | -4.47% 10.49% | ROIC | -10.26% | 52W Low | 7.4% ($3.38) | Perf 3Y | -73.83% |
| Dividend Est. | - | EV/EBITDA | 11.64 | EPS Y/Y TTM | -564.69% | Gross Margin | 11.29% | Volatility(W/M) | 3.25% 4.14% | Perf 5Y | -76.15% |
| Dividend TTM | - | EV/Sales | 0.76 | Sales Y/Y TTM | -29.52% | Oper. Margin | -0.11% | ATR (14) | 0.17 | Perf 10Y | -26.07% |
| Dividend Ex-Date | - | Quick Ratio | 0.67 | EPS Q/Q | -5891.5% | Profit Margin | -8.51% | RSI (14) | 38.42 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.67 | Sales Q/Q | -46.94% | SMA20 | -7.44% ($3.92) | Beta | 1.44 | Target Price | $7 |
| Payout | - | Debt/Eq | 1.51 | Earnings | 2026/7/29 | SMA50 | -8.73% ($3.98) | Rel Volume | 0.36 | Prev Close | $3.66 |
| Employees | 2300 | LT Debt/Eq | 1.25 | EPS/Sales Surpr. | -582.35% -11.6% | SMA200 | -29.76% ($5.17) | Avg Volume(3M) | 0.01M | Price | $3.63 |
| IPO | 1986/5/15 | Option/Short | Yes/Yes | Trades | 56 | Volume | 5,030 | Change | -0.82% |
A public sector services company that provides technology-driven healthcare and defense readiness solutions to U.S. federal government agencies. By combining capabilities in AI, cybersecurity, and clinical research, the company supports the Department of Health and Human Services (HHS), the Department of Veterans Affairs (VA), and the Department of Defense (DoD) in addressing complex national priorities.
Over the past 1 year, on the lower side
55% below its 1-year high.
Traded less than usual. That is 36% of its average volume.
DLHC has weak earnings and a weak balance sheet
Of every $100 in sales, $0.11 is lost.
Tap to view numbers
Growth has stalled
Earnings are expected to grow by -944.4% this year.
Tap to view numbers
Relative to sales, it looks cheap
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $21. Peers typically go for $122. Compared with its own 4-year average, it is 254% pricier now.
Tap to view numbers
Results came in about as expected
Mixed beats and misses
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -76.2%. The S&P 500 did +65% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership looks stable
Institutions hold 83.8%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #33 of 44 in the industry
Based on market cap of $53M.
TISI#31 Team Inc $110M PER - 
WFCF#32 Where Food Comes From Inc $81M PER 58.5 DLHC#33 DLH Holdings Corp $53M PER - 
YSXT#34 Ysx Tech Co Ltd $42M PER 11.1 
NTIP#35 Network-1 Technologies Inc $35M PER - 
FAQ
What kind of company is DLHC?
DLHC belongs to the Industrials sector and operates in the Specialty Business Services industry.
What is the market cap of DLHC?
The market cap of DLHC is approximately $53M, ranking 4,821 within its sector.
What is the 52-week high and low for DLHC?
DLHC has recorded a 52-week high of $8.10 and a low of $3.38.
